Files
Download Full Text (636 KB)
Document Type
Poster
Description
The purpose of this research was to identify the best course of action in response to a diagnosis of unprovoked pulmonary embolism.
•The evidence demonstrates non-inferiority status of new direct oral anticoagulants (DOAC) when indirectly compared to conventional warfarin therapy.
•Aspirin was also found effective in mitigating the risk of recurrence, but to a lesser extent than both DOAC agents and warfarin.
•DOACs are reasonable alternatives to conventional therapy. Attention to individual comorbidities may allow providers to find advantage with one therapy over another.
• The research, thus far, has not been able to identify a universally safe and an effective agent for all patients experiencing a first-time unprovoked pulmonary embolism.
•Additional research is needed to evaluate the duration of therapy and generate more robust data to recommend a specific therapeutic agent for all patients.
Department
Physician Assistant Studies
Date of Work
2020
Publication Date
2020
Keywords
Pulmonary embolism, warfarin, w direct oral anticoagulants (DOAC), Aspirin
Disciplines
Medicine and Health Sciences
Recommended Citation
Klucas, Christopher D., "Review of Anticoagulation Therapy in Unprovoked Pulmonary Embolism" (2020). Physician Assistant Scholarly Project Posters. 196.
https://commons.und.edu/pas-grad-posters/196